You are here


A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C

Habersetzer, F., Honnet, G., Bain, C., Maynard-Muet, M., Leroy, V., Zarski, J. P., Feray, C., Baumert, T. F., Bronowicki, J. P., Doffoel, M., Trepo, C., Agathon, D., Toh, M. L., Baudin, M., Bonnefoy, J. Y., Limacher, J. M., Inchauspe, G., Gastroenterology, 2011, 890-899 e1-4, 141, PMID: 21699798

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

Salaun, B., Zitvogel, L., Asselin-Paturel, C., Morel, Y., Chemin, K., Dubois, C., Massacrier, C., Conforti, R., Chenard, M. P., Sabourin, J. C., Goubar, A., Lebecque, S., Pierres, M., Rimoldi, D., Romero, P., Andre, F., Cancer Res, 2011, 1607-14, 71, PMID: 21343393

Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells

Cognet, C., Farnarier, C., Gauthier, L., Frassati, C., Andre, P., Magerus-Chatinet, A., Anfossi, N., Rieux-Laucat, F., Vivier, E., Schleinitz, N., Clin Immunol, 2010, 26-32, 135, PMID: 20093094

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells

Romagne, F., Andre, P., Spee, P., Zahn, S., Anfossi, N., Gauthier, L., Capanni, M., Ruggeri, L., Benson, D. M., Jr., Blaser, B. W., Della Chiesa, M., Moretta, A., Vivier, E., Caligiuri, M. A., Velardi, A., Wagtmann, N., Blood, 2009, 2667-77, 114, PMID: 19553639

Large scale expansion of Vgamma9Vdelta2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS "TCR gamma/delta+ T cell isolation kit"

Salot, S., Bercegeay, S., Dreno, B., Saiagh, S., Scaglione, V., Bonnafous, C., Sicard, H., J Immunol Methods, 2009, 12-8, 347, PMID: 19465023

DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells

Toutirais, O., Cabillic, F., Le Friec, G., Salot, S., Loyer, P., Le Gallo, M., Desille, M., de La Pintiere, C. T., Daniel, P., Bouet, F., Catros, V., Eur J Immunol, 2009, 1361-8, 39, PMID: 19404979

IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy

Thedrez, A., Harly, C., Morice, A., Salot, S., Bonneville, M., Scotet, E., J Immunol, 2009, 3423-31, 182, PMID: 19265120

Clinical analysis of human natural killer cells

Andre, P., Anfossi, N., Methods Mol Biol, 2008, 291-300, 415, PMID: 18370161

Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Bennouna, J., Bompas, E., Neidhardt, E. M., Rolland, F., Philip, I., Galea, C., Salot, S., Saiagh, S., Audrain, M., Rimbert, M., Lafaye-de Micheaux, S., Tiollier, J., Negrier, S., Cancer Immunol Immunother, 2008, 1599-609, 57, PMID: 18301889

Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product

Salot, S., Laplace, C., Saiagh, S., Bercegeay, S., Tenaud, I., Cassidanius, A., Romagne, F., Dreno, B., Tiollier, J., J Immunol Methods, 2007, 63-75, 326, PMID: 17716681